期刊文献+

中国丙型肝炎血清流行病学研究 被引量:307

A sero-epidemiological study on hepatitis C in China
原文传递
导出
摘要 目的了解中国现阶段丙型肝炎病毒(HCV)感染现状。方法利用中国疾病预防控制中心“2006年中国乙型病毒性肝炎血清流行病学调查”保留的血清,以美国Murex3.0和Ortho3.0抗一HCV试剂为金标准建立标准血清库,筛选中国抗一HCV检测试剂,并用ChironHCVRIBA3.0复核检测结果。结果中国1~59岁人群抗-HCV调整流行率为0.43%(95%CI:0.33%~0.53%),男性和女性抗-HCV流行率分别为O.46%和0.40%,城市和农村人群经调整后均为0.43%。东、中和西部地区人群抗-HCV流行率分别为0.37%(95%CI:0.21%~O.53%)、0.67%(95%C/:0.40%~0.94%)和0.31%(95%CI:0.20%~0.42%),3个地区人群抗-HCV流行率的差异无统计学意义;南方和北方地区人群抗-HCV流行率分别为0.29%(95%CI:0.21%~0.52%)和0.53%(95%CI:0.38%-0.64%)。结论经综合性防治,目前中国属丙型肝炎低流行区。 Objective To better understand and measure the status of hepatitis C virus (HCV) infection, we conducted a sero-epidemiological study using the remaining blood samples and data of the nationwide survey of hepatitis B in Chinese residents which was carried out in 2006. Methods The anti-HCV reagent was screened out from the reagents by the HCV infection blood serum plate with anti-HCV positives or negatives. This plate recognized the Murex 3.0 and Ortho 3.0 reagents as gold standards. Anti-HCV in the blood samples were tested using this reagent and confirmed by Chiron HCV RIBA 3.0 reagents. Results Among the population aged 1 year to 59 year-olds, the overall prevalence rate of anti-HCV was 0.43% (95%CI: 0.33%-0.53%), with the rates of anti-HCV among males and females as 0.46% and 0.40%, respectively. The prevalence rate of anti-HCV in urban area was 0.43%, and in rural area it was 0.43%. The prevalence rate of anti-HCV in the Eastern, Middle and Western areas were 0.37% (95% (21: 0.21%-0.53% ) , 0.67% (95% CI: 0.40%-0.94% ) and 0.31% (95% CI: 0.20%-0.42% ) respectively. The prevalence rates of anti-HCV for the three areas did not show significant differences, statistically. The prevalence rate of anti-HCV in the South and North areas were 0.29%(95%CI:0.21%-0.52%) and 0.53% (95%CI: 0.38%-0.64%) respectively. Conclusion Our data revealed that China was in the low prevalence area for hepatitis C infection and the results also suggested that the comprehensive measures for HCV control and prevention had been successfully achieved in the country.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2011年第9期888-891,共4页 Chinese Journal of Epidemiology
关键词 丙型肝炎 血清流行病学 Hepatitis C Sero-epidemiology
  • 相关文献

参考文献11

  • 1戴志澄,祁国明.中国病毒性肝炎血清流行病学调查(上卷),1992-1995.北京:科学技术文献出版社,1995:60-71.
  • 2Liang XF, Bi SL, Yang WZ, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine, 2009,27 : 6550-6557.
  • 3卫生部.全国人群乙型病毒性肝炎血清流行病学调查报告.北京:人民卫生出版社,2011:1-70.
  • 4Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003,38 Suppl: S 1042-1048.
  • 5Halasz R, Weiland O, Sallberg M. GB virus C/hepatitis G virus. Scand J Infect Dis, 2001,33 (8) : 572-580.
  • 6庄辉.重视丙型肝炎的研究[J].中华肝脏病杂志,2004,12(2):65-66. 被引量:44
  • 7Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C infection. Lancet Infect Dis, 2005,5 : 558-567.
  • 8Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol, 2008, 48: 148-162.
  • 9Mele A, Tosti ME, Marzolini A, et al. Prevemion of hepatitis C in Italy: lessons from surveillance of type-specific acute viral hepatitis. SEIEVA Collaborating Group. J Viral Hepat, 2000, 7 : 30-35.
  • 10Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis, 2005, 37: 622-628.

二级参考文献2

  • 1Edward Doo MD. Epidemiology and immunopathogenesis of chronic hepatitis B virus infection[J] 2003,Current Hepatitis Reports(2):79~81
  • 2M. Esumi,T. Rikihisa,S. Nishimura,J. Goto,K. Mizuno,Y.-H. Zhou,T. Shikata. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees[J] 1999,Archives of Virology(5):973~980

共引文献43

同被引文献1974

引证文献307

二级引证文献2488

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部